Search News
| 104.96 Delayed Data As of Apr 20 |  -0.93 / -0.88%Today’s Change | 94.20 Today|||52-Week Range 119.30 | -1.70% Year-to-Date |
The investment seeks to track the investment results of the NASDAQ Biotechnology Index- which contains securities of companies listed on NASDAQ that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by Nasdaq- Inc. The fund generally invests at least 90% of its assets in securities of the index and in depositary receipts representing securities of the index. It may invest the remainder of its assets in certain futures- options and swap contracts- cash and cash equivalents. It is non-diversified.
| Why These Small Cap Biotech ETFs are Soaring Apr 18 / Zacks.com - Paid Partner Content | Is PowerShares Dynamic Biotechnology & Genome Portfolio (PBE) a Hot ETF Right Now? Apr 12 / Zacks.com - Paid Partner Content |
| Albion Financial Group Buys iShares Nasdaq Biotechnology Index Fund, WisdomTree U.S.... Apr 17 / GuruFocus News - Paid Partner Content |
| 1 month | -5.06% | 3 years | -4.01% | |
| 3 months | -6.30% | 5 years | +12.96% | |
| 1 year | +8.75% | Since inception | +7.05% |
| Previous close | $105.89 |
| Open day’s range | 104.69 – 106.09 |
| Net asset value (NAV) | 104.99 (04/20/2018) |
| Daily volume | 2,099,499 |
| Average volume (3 months) | 2,826,976 |
| IBB | Category | |
|---|---|---|
| Performance 5-yr return | +12.96% | +14.29% |
| Expense Gross exp ratio | 0.47% | 1.30% |
| Risk 5 year sharpe ratio | 0.72 | 0.92 |
| Net assets | $9.0B | $3.0B |
| Average market cap | $15.7B | $10.0B |
| Average P/E | 29.0 | 22.2 |
| Dividend / Share | -- | 0.30% |
| XLV Health Care Select Sector SPDR® Fund |
| FHLC Fidelity® MSCI Health Care Index ETF |
| VHT Vanguard Health Care Index Fund ETF Shar... |
| Healthcare | 99.91% |
| Business service | 0.09% |
| Consumer goods | 0.00% |
| Consumer service | 0.00% |
| Energy | 0.00% |
| CELG Celgene | 8.29% |
| GILD Gilead Sciences | 7.75% |
| BIIB Biogen | 7.67% |
| AMGN Amgen | 7.51% |
| VRTX Vertex Pharmaceuticals Inc | 5.57% |
| REGN Regeneron Pharmaceuticals | 4.35% |
| ILMN Illumina Inc | 4.20% |
| ALXN Alexion Pharmaceuticals Inc | 3.39% |
| MYL Mylan NV | 3.03% |
| INCY Incyte Corp | 2.42% |
